PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

No impending CR, not at least until 008 results drop. Why would...

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    No impending CR, not at least until 008 results drop. Why would PR help pay off short sellers when they cost him his performance rights?

    I've always said the first half of 2022 would be quiet, while the action will pick up significantly in the second half of 2022. Now just imagine if PAR were to announce that they were going to apply for TGA approval once the results for 008 drop? Now why else do you think they've brought in Marco so early?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.